Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskPositive

ARCTURUS THERAPEUTICS HOLDINGS INC.

Filed: Jun 5, 2026CIK: 0001768224Health Care
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Arcturus Therapeutics held its annual stockholder meeting on June 5, 2026, and elected eight directors to its Board, including Dr. Moncef Slaoui and Dr. Peter Farrell. This board composition change signals potential strategic shifts in the company's direction and governance.

Key Takeaways

Eight directors were elected to the Board of Directors at the annual stockholder meeting, including notable figures such as Dr. Moncef Slaoui and Dr. Peter Farrell

The meeting achieved quorum with 21,435,189 shares present, representing 75.5% of the 28,423,069 shares entitled to vote

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJun 5, 2026
Item5.02
CategoryExecutive Change
CIK0001768224
Accession #0001768224
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
board changeleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings